The	O
Met	O
proto	O
-	O
oncogene	O
mesenchymal	B-Cell
to	O
epithelial	B-Cell
cell	I-Cell
conversion	O
.	O

Coexpression	O
of	O
the	O
human	O
Met	O
receptor	O
and	O
its	O
ligand	O
,	O
hepatocyte	O
growth	O
factor	O
/	O
scatter	O
factor	O
(	O
HGF	O
/	O
SF	O
)	O
,	O
in	O
NIH	B-Cell
3T3	I-Cell
fibroblasts	I-Cell
causes	O
the	O
cells	B-Cell
to	O
become	O
tumorigenic	O
in	O
nude	O
mice	O
.	O

The	O
resultant	O
tumors	B-Cancer
display	O
lumen	B-Immaterial_anatomical_entity
-	O
like	O
morphology	O
,	O
contain	O
carcinoma	B-Cancer
-	I-Cancer
like	I-Cancer
focal	I-Cancer
areas	I-Cancer
with	O
intercellular	B-Cellular_component
junctions	I-Cellular_component
resembling	O
desmosomes	B-Cellular_component
,	O
and	O
coexpress	O
epithelial	B-Cell
(	O
cytokeratin	O
)	O
and	O
mesenchymal	B-Cell
(	O
vimentin	O
)	O
cytoskeletal	B-Cellular_component
markers	O
.	O

The	O
tumor	B-Cell
cells	I-Cell
also	O
display	O
enhanced	O
expression	O
of	O
desmosomal	B-Cellular_component
and	O
tight	B-Cellular_component
-	I-Cellular_component
junction	I-Cellular_component
proteins	O
.	O

The	O
apparent	O
mesenchymal	B-Cell
to	O
epithelial	B-Cell
conversion	O
of	O
the	O
tumor	B-Cell
cells	I-Cell
mimics	O
the	O
conversion	O
that	O
occurs	O
during	O
embryonic	B-Organ
kidney	I-Organ
development	O
,	O
suggesting	O
that	O
Met	O
-	O
HGF	O
/	O
SF	O
signaling	O
plays	O
a	O
role	O
in	O
this	O
process	O
as	O
well	O
as	O
in	O
tumors	B-Cancer
that	O
express	O
both	O
epithelial	B-Cell
and	O
mesenchymal	B-Cell
markers	O
.	O

